Pathobiology of pulmonary artery hypertension;Génétique et physiopathologie de l'hypertension artérielle pulmonaire primitive ou secondaire

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 8, 2003, Pages 1529-1545

  Adnot, Serge ^a   Eddahibi, Saadia ^b   Grosgogeat, Yves ^b   Godeau, Pierre ^b   Caen, Jacques ^b   Queneau, Patrice ^b   Jaffiol, Claude ^b   Loisance, Daniel ^b   Dreux, Claude ^b   David, Georges ^b   Parodi, André ^b  

^a FACULTÉ DE MÉDECINE   (France)

^b NONE

Author keywords

Bone morphogenetic proteins; Hypertension, pulmonary; Myocytes, smooth muscle; Serotonin

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR II; SEROTONIN; SEROTONIN TRANSPORTER; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLELE; ARTERY CONSTRICTION; ARTERY DISEASE; ARTERY MUSCLE; ARTERY WALL; ARTICLE; BONE MORPHOGENETIC PROTEIN RECEPTOR II GENE; CELL PROLIFERATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; FAMILIAL DISEASE; FATALITY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERPLASIA; INFANT DISEASE; MOLECULAR MECHANICS; MUSCLE HYPERTROPHY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT; PHENOTYPE; PROTEIN ANALYSIS; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; GENETICS; METABOLISM; MUTATION; REVIEW;

HUMANS; HYPERTENSION, PULMONARY; MUTATION; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 3442899892     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33889-0     Document Type: Article

References (16)

1. RUBIN LJ. - Primary pulmonary hypertension. N. Engl. J. Med., 1997, 336, 111-117.
2. ATKINSON C., STEWART S., UPTON PD., MACHADO R., THOMSON JR., TREMBATH RC et al. - Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation, 2002, 105, 1672-8.
3. EDDAHIBI S., RAFFESTIN B., HAMON M., ADNOT S. - Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension ? J. Lab. Clin. Med., 2002, 139, 194-201.
4. DENG Z., MORSE JH., SLAGER SL., CUERVO N., MOORE KJ., VENETOS G., et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet., 2000, 67, 737-744.
5. LANE KB., MACHADO RD., PAUCIULO MW., THOMSON JR., PHILIPS III JA., LOYD JE et al. - Heterozygous germline mutations in BMPR2, encoding a TGFb receptor, cause familial primary pulmonary hypertension. Nature Genet. 2000, 26, 81-84.
6. NEWMAN JH., WHEELER L., LANE KB., LOYD E., GADDIPATI R., PHILLIPS JA., et al. - Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med. 2001, 345, 319-24.
7. TREMBATH RC., THOMSON JR., MACHADO RD., MORGAN NV., ATKINSON C., WINSHIP I et al. - Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N. Engl J. Med., 2001, 345, 325-34.
8. YUAN XJ., WANG J., JUHASZOVA M., GAINE SP., RUBIN LJ. - Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet, 1998, 351, 726-7.
9. EDDAHIBI S., HUMBERT M., FADEL E., RAFFESTIN B., DARMON M., CAPRON F. et al. - Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest., 2001, 108, 1141-1150.
10. EDDAHIBI S., HUMBERT M., SEDIAME S., CHOUAID C., PARTOVIAN C., MAITRE B et al. - Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am. J. Respir Crit. Care. Med., 2000, 162, 1493-9.
11. ABENHAIM L., MORIDE Y., BRENOT F., RICH S., BENICHOU J., KURZ X., et al. - Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N. Engl. J. Med., 1996, 335, 609-616.
12. HERVÉ P., LAUNAY JM., SCOBOHACI ML., BRENOT F., SIMONNEAU G., PETIT-PRETZ P et al. - Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med., 1995, 99, 249-254.
13. EDDAHIBI S., FABRE V., BONI C., MARTRES MP., RAFFESTIN B., HAMON M., et al. - Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells-Relationship with the mitogenic action of serotonin. Circ Res. 1999, 84, 329-336.
14. LEE SL., WANG WW., MOORE BJ., FANBURG BL. - Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ. Res., 1991, 68, 1362-1368.
15. EDDAHIBI S., HANOUN N., LANFUMEY L., LESCH K., RAFFESTIN B., HAMON et al. - Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest., 2000, 105, 1555-1562.
16. EDDAHIBI S., CHAOUAT A., MORRELL N., FADEL E., FUHRMAN C., BUGNET AS et al. - Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. Circulation, 2003.